Brexit’s Impact on Parallel Trade

In this ISSUE

Jean Drouin, Clarify Health: Harnessing the Power of Machine Learning

One Mechanism of Action Targets Numerous Oncology Indications

Small Pharma Increases Valuation Through Revenue Diversification

Europe

Brexit's Impact on Parallel Trade

Despite a "temporary fix" at the ready, pharma supply repercussion s loom if exit deal isn't reached this month. Reflector reports
… /Read more/

Patient Adherence: A Hard Pill to Swallow?
North America: Thursday, April 11, 2019 at 1pm EDT | 12pm CDT | 10am PDT
Asia-Pacific: Thursday, April 11, 2019 at 11:30am IST | 2pm CST | 3pm JST

FDA Will Miss Gottlieb's Leadership

Scott Gottlieb's FDA tenure included record new drug approvals and steps taken to curb opioid abuse. Jill Wechsler reports
… /Read more/

Using Real-World Evidence for U.S. Regulatory Decision-Making: What Pharma Needs to Know
Wednesday, March 20, 2019 at 1pm EDT | 12pm CDT | 10am PDT

Global

Cystic Fibrosis: The Importance of Patient Advocacy

Eloxx Pharmaceuticals CEO Bob Ward discusses this underserved patient segment
… /Read more/

Japan Market Entry: How to Navigate the Clinical Development Regulatory Environment and Best Methods to Utilize Opportunities
Tuesday, March 19, 2019 at 6pm EDT

Marketing

How to Get Your Marketing Team to Drive with Data

Creating a culture of analytics will help you get the most out of your marketing efforts, writes Justin Grossman
… /Read more/

Marketing

Are Pharma Marketers Fighting the Last War?

If payers are the fastest growing influencers in healthcare (and they are), why is it that payer-targeted advertising campaigns are often an afterthought? Amber Gilbert reports
… /Read more/

Calendar

/ March 18– 21: DCAT Week '19 /

New York City, NY

/ March 20–22: 15^th Life Sciences Accounting and Reporting Congress /

Philadelphia, PA

/ March 20–March 21: Partnering with IDNs Biopharma Strategy Summit West /

Scottsdale, AZ

/ March 27–28: 12^th Annual Expanded Access Programs /

Philadelphia, PA

/ April 16–17: eyeforpharma Philadelphia /

Philadelphia, PA

/ May 15: MDR Workshop: Transitioning to the EU MDR and Managing Legacy Devices /

Brussels, Belgium

/ June 12–13: Rare Disease Innovation and Partnering Summit /

Boston, MA

Industry update

// Sanofi (Paris, France) appointed Ameet Nathwani , M.D., as Chief Digital Officer. // Celyad (Mont-Sant-Guibert, Belgium) announced the appointment of Anne Moore, Ph.D., to the position of Vice President Corporate Strategy. // H. Lundbeck A/S (Valby, Denmark) appointed Keld Flintholm Jørgensen as Chief Business Officer heading Corporate Strategy & Business Development from April 4, 2019. // Kiadis Pharma (Amsterdam, The Netherlands) announced the appointments of Dirk de Naeyer as Chief Operations Officer and Martine Nolan as Head of Quality Assurance. // Dr. Athanasios Papadopoulos joined Emergex (Oxford, UK) as Chief Medical Officer. // Mundipharma (Cambridge, UK) appointed Patrice Grand as European Director of Corporate Communications. // Achilles Therapeutics (Stevenage, UK) appointed Dr. Markus Dangl as Chief Scientific Officer.

update my profile / advertise with us / print subscribe / digital subscribe / visit pharmexec.com